Paper Details

  1. Home
  2. Paper Details

Evaluation of the safety and feasibility of rapid rituximab infusion.

Author: BarryFiona, CatherwoodAmanda, ChaplinKylie, ElliottLisa, GrecoKim, LangDora, McGaheyWendy, NilsenJill, ProuseJanette, SinghalNimit

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Evaluation StudyResearch that systematically evaluates the effectiveness of a particular program or policy. It measures its outcomes and provides important information for future decision-making.

Overview

Rapid infusion of rituximab over 90 minutes was safe and feasible in patients with cancer.
Paper Details　
Original Abstract of the Article :
AIM: To assess safety of rapid infusion by measuring infusion-related side effects and toxicities. METHODS: Participants received the first rituximab infusion according to the manufacturers' recommendations. If well-tolerated, they then received the second and subsequent infusions at a rate of 20% ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1743-7563.2011.01487.x

データ提供：米国国立医学図書館（NLM）

Rapid Rituximab Infusion: Balancing Speed and Safety

This research investigated the safety and feasibility of rapid rituximab infusion, a treatment commonly used for various cancers. The study aimed to evaluate the rate of infusion-related side effects and toxicities associated with a shortened infusion time.

Rapid Rituximab Infusion: A Safe and Feasible Option

The results showed that rapid rituximab infusion, administered over 90 minutes, was safe and feasible for most patients treated in an ambulatory cancer center. While some patients experienced mild side effects, the majority tolerated the rapid infusion well, demonstrating the potential to improve efficiency and resource utilization.

Personalized Medicine: Tailoring Treatment to Individual Needs

The study highlights the importance of personalized medicine, ensuring that treatment regimens are tailored to individual patient needs and tolerances. Just as a camel adjusts its pace based on the terrain, healthcare professionals should carefully consider patient factors when determining the optimal infusion rate for rituximab.

Dr.Camel's Conclusion

This study demonstrates the potential to optimize rituximab infusion strategies, balancing speed and safety. Like a camel navigating the desert, we must find the right balance to achieve our goals while minimizing risks. This research provides valuable insights into how we can continue to improve cancer treatment for patients.

Date :
  1. Date Completed 2012-06-14
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

22369446

DOI: Digital Object Identifier

10.1111/j.1743-7563.2011.01487.x

Related Literature

Article Analysis
・Side Effects of promethazine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.